Visualant, Inc. announced that it expects to receive $0.4 million in funding.
January 30, 2016
Share
Visualant, Inc. (OTCPK:VSUL) announced that it has entered into a securities purchase agreement to issue convertible promissory notes and warrants for gross proceeds of $395,000 in a round of funding on January 31, 2016. The company will issue securities pursuant to exemption provided under Regulation D. Promissory notes will be convertible into common shares to the company. The transaction included participation from five investors.
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
KNOW LABS, INC. 
